Evidence map›Paper›PMID 26317248›Full record

ArticleNutrition and cancer2015

Association Between Prediagnostic Serum 25-Hydroxyvitamin D Concentration and Glioma.

Victoria Zigmont, Amy Garrett, Jin Peng, Michal Seweryn, Grzegorz A Rempala, Randall Harris, Christopher Holloman, Thomas E Gundersen, Anders Ahlbom, Maria Feychting and 3 more

Abstract read
In one paragraph

Article in Nutrition and cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Exploring the Molecular Mechanism of 1,25(OH)Current issues in molecular biology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Anti-tumor effects of vitamin D in glioblastoma: mechanism and therapeutic implications.Laboratory investigation; a journal of technical methods and pathology · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Victoria Zigmonta Comprehensive Cancer Center and Division of Epidemiology, College of Public Health , Ohio State University , Columbus , Ohio , USA.
Amy Garretta Comprehensive Cancer Center and Division of Epidemiology, College of Public Health , Ohio State University , Columbus , Ohio , USA.
Jin Pengb Division of Epidemiology , College of Public Health, Ohio State University , Columbus , Ohio , USA.
Michal Sewerynd Division of Biostatistics, College of Public Health and Mathematical Biosciences Institute , Ohio State University , Columbus , Ohio , USA.
Grzegorz A Rempalad Division of Biostatistics, College of Public Health and Mathematical Biosciences Institute , Ohio State University , Columbus , Ohio , USA.
Randall Harrisa Comprehensive Cancer Center and Division of Epidemiology, College of Public Health , Ohio State University , Columbus , Ohio , USA.
Christopher Hollomane Department of Statistics , Ohio State University , Columbus , Ohio , USA.
Thomas E Gundersenf Vitas Analytic Services , Oslo , Norway.
Anders Ahlbomg Institute of Environmental Medicine , Division of Epidemiology, Karolinska Institutet , Stockholm , Sweden.
Maria Feychtingg Institute of Environmental Medicine , Division of Epidemiology, Karolinska Institutet , Stockholm , Sweden.
Tom Borge Johannesenh Department of Registration , Cancer Registry of Norway , Oslo , Norway.
Tom Kristian Grimsrudh Department of Registration , Cancer Registry of Norway , Oslo , Norway.
Judith Schwartzbauma Comprehensive Cancer Center and Division of Epidemiology, College of Public Health , Ohio State University , Columbus , Ohio , USA.
The Ohio State University · USCancer Registry of Norway · NOKarolinska Institutet · SEVitas (Norway) · NO

Funding

Allergic Condition Susceptibility Polymorphisms and Glioma RiskR01CA122163 · NCI · OHIO STATE UNIVERSITY · PI SCHWARTZBAUM, JUDITH · 2008 to 2012
$2.6M
NCI NIH HHS R01 CA122163NCI NIH HHS R01CA122163
6 · The paper itself

Abstract

There are no previous studies of the association between prediagnostic serum vitamin D concentration and glioma. Vitamin D has immunosuppressive properties; as does glioma. It was, therefore, our hypothesis that elevated vitamin D concentration would increase glioma risk. We conducted a nested case-control study using specimens from the Janus Serum Bank cohort in Norway. Blood donors who were subsequently diagnosed with glioma (n = 592), between 1974 and 2007, were matched to donors without glioma (n = 1112) on date and age at blood collection and sex. We measured 25-hydroxyvitamin D [25(OH)D], an indicator of vitamin D availability, using liquid chromatography coupled with mass spectrometry. Seasonally adjusted odds ratios (ORs) and 95% confidence intervals (95% CIs) were estimated for each control quintile of 25(OH)D using conditional logistic regression. Among men diagnosed with high grade glioma >56, we found a negative trend (P = .04). Men diagnosed ≤ 56 showed a borderline positive trend (P = .08). High levels (>66 nmol/L) of 25(OH)D in men >56 were inversely related to high grade glioma from ≥2 yr before diagnosis (OR = 0.59; 95% CI = 0.38, 0.91) to ≥15 yr before diagnosis (OR = 0.61; 95% CI = 0.38,0.96). Our findings are consistent long before glioma diagnosis and are therefore unlikely to reflect preclinical disease.

Indexed as

AdultAgedAge FactorsCase-Control StudiesCentral Nervous System NeoplasmsFemaleGliomaHumansMaleMiddle AgedNorwaySex FactorsVitamin DYoung Adult25-hydroxyvitamin DVitamin D

Identifiers

PMID26317248
PMCPMC4827350
OpenAlexW1838739921

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.